Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine Versus a Licensed Comparator in Children

ClinicalTrials.gov ID: NCT00764790

Public ClinicalTrials.gov record NCT00764790. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 2:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Immunogenicity and Safety of GSK Biologicals' Thimerosal-free TIV Flu Vaccine Versus a Licensed Comparator in Children

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the immunogenicity and the safety of GlaxoSmithKline Biologicals' seasonal influenza vaccine, Fluarix, compared to Fluzone (a US-licensed vaccine) in children, 6 to 35 months of age.

Study identification

NCT ID
NCT00764790
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
3,317 participants

Conditions and interventions

Conditions

Interventions

Biological

Eligibility (public fields only)

Age range
6 Months to 35 Months
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 1, 2008 (Type not available)
Primary completion
Mar 5, 2009 (Actual)
Completion
Jun 1, 2009 (Actual)
Last update posted
Jul 31, 2018

2008 – 2009

United States locations

U.S. sites
62
U.S. states
27
U.S. cities
61
Facility City State ZIP Site status
GSK Investigational Site Birmingham Alabama 35205 —
GSK Investigational Site Birmingham Alabama 35244 —
GSK Investigational Site Dothan Alabama 36305 —
GSK Investigational Site Benton Arkansas 72019 —
GSK Investigational Site Conway Arkansas 72034 —
GSK Investigational Site Fayetteville Arkansas 72703 —
GSK Investigational Site Jonesboro Arkansas 72401 —
GSK Investigational Site Little Rock Arkansas 72205 —
GSK Investigational Site Huntington Beach California 92647 —
GSK Investigational Site Long Beach California 90806 —
GSK Investigational Site Paramount California 90723 —
GSK Investigational Site Sacramento California 95816 —
GSK Investigational Site San Francisco California 94102 —
GSK Investigational Site West Covina California 91790 —
GSK Investigational Site Longmont Colorado 80501 —
GSK Investigational Site Norwich Connecticut 06360 —
GSK Investigational Site Nampa Idaho 83686 —
GSK Investigational Site DeKalb Illinois 60115 —
GSK Investigational Site New Albany Indiana 47150 —
GSK Investigational Site Arkansas City Kansas 67005 —
GSK Investigational Site Newton Kansas 67114 —
GSK Investigational Site Wichita Kansas 67207 —
GSK Investigational Site Bardstown Kentucky 40004 —
GSK Investigational Site Louisville Kentucky 40207 —
GSK Investigational Site Bossier City Louisiana 71111 —
GSK Investigational Site Metairie Louisiana 70006 —
GSK Investigational Site Stevensville Michigan 49127 —
GSK Investigational Site Saint Paul Minnesota 55108 —
GSK Investigational Site St Louis Missouri 63141 —
GSK Investigational Site Omaha Nebraska 68134 —
GSK Investigational Site Henderson Nevada 89015 —
GSK Investigational Site Cortland New York 13045 —
GSK Investigational Site Boone North Carolina 28607 —
GSK Investigational Site Cary North Carolina 27518 —
GSK Investigational Site Raleigh North Carolina 27609 —
GSK Investigational Site Fargo North Dakota 58103 —
GSK Investigational Site Austintown Ohio 44515 —
GSK Investigational Site Cincinnati Ohio 45245 —
GSK Investigational Site Cleveland Ohio 44121 —
GSK Investigational Site Dayton Ohio 45406 —
GSK Investigational Site Gresham Oregon 97030 —
GSK Investigational Site Erie Pennsylvania 16505 —
GSK Investigational Site Greenville Pennsylvania 16125 —
GSK Investigational Site Latrobe Pennsylvania 15650 —
GSK Investigational Site Pittsburgh Pennsylvania 15236 —
GSK Investigational Site Uniontown Pennsylvania 15401 —
GSK Investigational Site Wexford Pennsylvania 15090 —
GSK Investigational Site Charleston South Carolina 29406 —
GSK Investigational Site Clarksville Tennessee 37043 —
GSK Investigational Site Jackson Tennessee 38305 —
GSK Investigational Site Kingsport Tennessee 37660 —
GSK Investigational Site Austin Texas 78705 —
GSK Investigational Site Fort Worth Texas 76135 —
GSK Investigational Site Houston Texas 77055 —
GSK Investigational Site San Angelo Texas 76904 —
GSK Investigational Site Bountiful Utah 84010 —
GSK Investigational Site Layton Utah 84041 —
GSK Investigational Site Murray Utah 84107 —
GSK Investigational Site Provo Utah 84604 —
GSK Investigational Site Roy Utah 84067 —
GSK Investigational Site South Jordan Utah 84095 —
GSK Investigational Site Burke Virginia 22015 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00764790, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 31, 2018 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00764790 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →